Opendata, web and dolomites
H2020 projects about "bioavailable"
The page lists 15 projects related to the topic "bioavailable".
| # | |||
|---|---|---|---|
| 1 | ICE-OTOPE | “Weathering and nutrient export from subglacial environments: A novel stable isotope approach” | 2015 |
| 2 | ODEON | Online DEposition over OceaNs: Modeling the effect of air pollution on ocean bio-geochemistryin an Earth System Model | 2016 |
| 3 | PEP-PRO-RNA | Peptide-derived bioavailable macrocycles as inhibitors of protein-RNA and protein-protein interactions | 2016 |
| 4 | PHOSPHOTRAC | Speciation, sources, and fate of atmospheric organic phosphorus over the Mediterranean Sea: A missing piece of the P cycle? | 2016 |
| 5 | Curtana | Patented small molecule therapeutics that target cancer stem cells for the treatment of glioblastoma and other brain cancers | 2017 |
| 6 | ONCOPHAGY | Novel Atg4B-inhibitors and dual [Atg4B-carbonic anhydrase]inhibitors for interfering with cytoprotective mechanisms of cancercells in the acidic tumor micro-environment. | 2017 |
| 7 | GrIS-Melt | Impacts of Greenland Ice Sheet melt on primary productivity and carbon cycling in Greenland coastal ecosystems | 2017 |
| 8 | IRONCOMM | Investigating the role of bacteria-produced siderophores in satisfying diatom Fe requirements. | 2017 |
| 9 | ICICLES | Iron and Carbon Interactions and Biogeochemical CycLing in Subglacial EcosystemS | 2018 |
| 10 | incPRINT-DRUG | incPRINT as a platform for RNA-targeted drug discovery | 2019 |
| 11 | IBL-302 | Inflection Bioscience unique dual mechanism, small molecule, orally available therapeutic targeting major unmet medical needs in breast cancer | 2019 |
| 12 | MAXIPLAN | Cultivated barnacle offspring – the solution for realizing marine aquaculture growth | 2019 |
| 13 | CYPNASH | Validation of a novel class of cyclophilin inhibitors for the treatment of non-alcoholic steatohepatitis | 2019 |
| 14 | Oralis | Oralis, The first oral human insulin treatment for Type 2 Diabetes Mellitus | 2019 |
| 15 | ERA4TB | EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS | 2020 |